Cryo-Cell International Files Proxy Statement for Annual Meeting

TL;DR

Cryo-Cell Intl (CRYO) proxy filed. Annual meeting Oct 29. Vote your shares!

AI Summary

Cryo-Cell International, Inc. filed its definitive proxy statement on October 7, 2024, for its annual meeting of stockholders. The filing, designated as DEF 14A, outlines the company's governance and proposals to be voted on by shareholders. The meeting is scheduled for October 29, 2024, and the company is headquartered in Oldsmar, Florida.

Why It Matters

This filing provides shareholders with crucial information regarding company management, voting matters, and the overall direction of Cryo-Cell International, Inc., enabling informed participation in corporate governance.

Risk Assessment

Risk Level: low — This is a routine DEF 14A filing for an annual meeting, not indicating any immediate financial distress or significant operational changes.

Key Numbers

• 20241029 — Annual Meeting Date (Shareholders will vote on company matters on this date.)
• 20241007 — Filing Date (Date the proxy statement was submitted to the SEC.)

Key Players & Entities

• CRYO CELL INTERNATIONAL INC (company) — Registrant
• 0001193125-24-233861 (filing_id) — Accession Number
• 20241007 (date) — Filing Date
• 20241029 (date) — Meeting Date
• 700 BROOKER CREEK BLVD SUITE 1800 OLDSMAR, FL 34677 (address) — Company Headquarters

FAQ

Key Financial Figures

• $1 billion — trading portfolio ranging in size from $1 billion to $7 billion. In addition to the finan
• $7 billion — olio ranging in size from $1 billion to $7 billion. In addition to the finance experience,
• $30 million — on (NBA) players totaling approximately $30 million. Mr. Portnoy graduated Phi Beta Kappa f
• $60 million — with a purchase budget of approximately $60 million per year. From 2003-2008, Mr. Mizrahi s

Filing Documents

• d861228ddef14a.htm (DEF 14A) — 218KB
• g861228g00p01.jpg (GRAPHIC) — 212KB
• g861228g00p02.jpg (GRAPHIC) — 225KB
• g861228g04g04.jpg (GRAPHIC) — 26KB
• 0001193125-24-233861.txt ( ) — 855KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 13 EXECUTIVE AND DIRECTOR COMPENSATION 15 SUMMARY COMPENSATION TABLE 15 RELATED PARTY TRANSACTIONS 20 PROPOSAL 3 ADVISORY VOTE ON EXECUTIVE COMPENSATION 21 PROPOSAL 4 OTHER BUSINESS 22 2025 ANNUAL MEETING STOCKHOLDER PROPOSALS 22 Table of Contents PROXY STATEMENT CRYO-CELL INTERNATIONAL, INC. This Proxy Meeting will be held at Cryo-Cell International, Inc., 700 Brooker Creek Blvd., Suite 1800, Oldsmar, Florida 34677, on October 29, 2024 at 11:00 a.m., local time. This Proxy Statement and the Notice of Annual Meeting of Stockholders are being provided to stockholders beginning on or about October 7, 2024. A copy of the Companys Annual Report on Form 10-K for the fiscal year ended November 30, 2023 accompanies this Proxy Statement. The Company, a Delaware corporation, has its principal executive offices at 700 Brooker Creek Blvd., Suite 1800, Oldsmar, Florida 34677. The Annual Meeting is being held for the purposes set forth in the accompanying Notice of Annual Meeting of Stockholders. Stockholders Entitled to Vote Only holders of record of our shares of common stock at the close of business on September 20, 2024 are entitled to notice of and to vote at the Annual Meeting and at any adjournments or postponements of the Annual Meeting. Each share entitles its holder to one vote on each matter presented at the Annual Meeting. The holders of one-third of the shares entitled to vote at the Annual Meeting must be present in person or represented by proxy in order to constitute a quorum for all matters to come before the Annual Meeting. On the record date, there were 8,062,159 shares outstanding. Vote Required As provided in the Companys bylaws,

View Full Filing

View this DEF 14A filing on SEC EDGAR